A coalition of states allege a string of drug companies arranged a scheme that would raise generic drug prices in some instances by more than 1,000% and reduce competition for generic drugs, according to a recent press release from the New Jersey Attorney General’s Office.
The drugs involved include antidepressants, anti-inflammatory drugs, contraceptives, drugs to treat cancer, high BP, HIV, oral antibiotics and many more, the release also stated.
“The generic drug market is structured in a way that allows generic drug manufacturers, including but not limited to the Defendants, to
Uncategorized